Lupin Announces the Approval and Launch of Brivaracetam Oral Solution in the United States
PR Newswire —
MUMBAI, India and NAPLES, Fla., Feb. 24, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the U.S. FDA for its Abbreviated New Drug Application (ANDA) for...